Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-19

Clinical Trial Update: Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update compares PolarX and Arctic Front cryoballoons for pulmonary vein isolation in symptomatic paroxysmal atrial fibrillation; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arctic Front Cryoballoon (cryoballoon ablation catheter)
  • PolarX Cryoballoon (cryoballoon ablation catheter)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Paroxysmal Atrial Fibrillation | Phase 4 | Status: ACTIVE_NOT_RECRUITING